Parallax Volatility Advisers L.P. Takes $38,000 Position in Clover Health Investments, Corp. (NASDAQ:CLOV)

Parallax Volatility Advisers L.P. purchased a new stake in shares of Clover Health Investments, Corp. (NASDAQ:CLOV) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 13,447 shares of the company’s stock, valued at approximately $38,000.

Several other large investors have also bought and sold shares of the company. Charles Schwab Investment Management Inc. raised its stake in shares of Clover Health Investments by 5.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 3,000,505 shares of the company’s stock valued at $8,461,000 after acquiring an additional 150,550 shares during the period. Connor Clark & Lunn Investment Management Ltd. raised its position in Clover Health Investments by 75.7% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,128,171 shares of the company’s stock worth $3,181,000 after buying an additional 485,987 shares during the last quarter. XTX Topco Ltd acquired a new stake in shares of Clover Health Investments during the 2nd quarter worth approximately $932,000. AQR Capital Management LLC grew its stake in Clover Health Investments by 4.6% in the 2nd quarter. AQR Capital Management LLC now owns 729,706 shares of the company’s stock valued at $898,000 after acquiring an additional 32,288 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in Clover Health Investments during the 3rd quarter worth $1,228,000. 19.77% of the stock is owned by hedge funds and other institutional investors.

Clover Health Investments Stock Performance

NASDAQ:CLOV opened at $3.36 on Friday. The stock has a fifty day moving average price of $3.67 and a two-hundred day moving average price of $2.51. The stock has a market capitalization of $1.68 billion, a price-to-earnings ratio of -16.75 and a beta of 1.94. Clover Health Investments, Corp. has a 1 year low of $0.61 and a 1 year high of $4.71.

Clover Health Investments (NASDAQ:CLOV) last issued its quarterly earnings results on Wednesday, November 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.01. The firm had revenue of $330.99 million for the quarter, compared to analyst estimates of $347.60 million. Clover Health Investments had a negative return on equity of 25.46% and a negative net margin of 5.92%. During the same period last year, the company earned ($0.09) EPS. On average, analysts predict that Clover Health Investments, Corp. will post -0.12 EPS for the current year.

Wall Street Analyst Weigh In

Separately, UBS Group began coverage on shares of Clover Health Investments in a report on Monday, October 7th. They issued a “neutral” rating and a $4.00 price objective on the stock.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.